Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25060209 |
US |
43 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 602 | 25060321 |
US |
56 | 2 |
Dermatitis atopic, Erythema, Pruritus, Skin irritation, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 603 | 25060344 |
US |
2 | |
Wheezing, Dyspnoea, Pruritus, Erythema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 604 | 25060377 |
US |
84 | 2 |
Alopecia, Peripheral swelling, Swelling, Pruritus, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 605 | 25060428 |
US |
2 | |
Bacterial infection, Erythema, Skin infection, Oropharyngeal pain, Fungal infection, Rash, Inappropriate schedule of product administration, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 606 | 25060445 |
AR |
63 | 2 |
General physical health deterioration, Skin irritation, Swelling face, Eye swelling, Skin erosion, Drug ineffective, Erythema, Pruritus, Rash, Facial pain, |
||||
PANITUMUMAB, |
||||
| 607 | 25060648 |
US |
55 | 1 |
Haemorrhage, Rash, Erythema, Swelling, |
||||
AXITINIB, PEMBROLIZUMAB, |
||||
| 608 | 25060658 |
US |
80 | 2 |
Neuropathy peripheral, Cervical spinal stenosis, Haemolysis, Transient ischaemic attack, Upper respiratory tract infection, Bronchospasm, Sleep disorder, Upper-airway cough syndrome, Alopecia, Dyspnoea exertional, Dyspepsia, Nocturia, Anxiety, Leukocytosis, Sarcopenia, Iron metabolism disorder, Dry skin, Erythema, Ecchymosis, Raynaud^s phenomenon, Skin lesion, Livedo reticularis, Cardiac murmur, Varicose vein, Fatigue, Rhinorrhoea, Dry mouth, Mouth ulceration, Dysphonia, Lymphadenopathy, Dysphagia, Skin hypopigmentation, Increased tendency to bruise, Temperature intolerance, Dry eye, Constipation, Abdominal distension, Affect lability, Blood creatine phosphokinase decreased, Red blood cell sedimentation rate abnormal, |
||||
ETANERCEPT, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, MOMETASONE FUROATE, MAGNESIUM OXIDE, CELECOXIB, LORATADINE, LORATADINE ORAL, ABATACEPT, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALBUTEROL SULFATE, ERGOCALCIFEROL, METHYLPREDNISOLONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, HYDROCODONE BITARTRATE, OXYCODONE, GABAPENTIN, AMOXICILLIN AND CLAVULANATE POTASSIUM, BACLOFEN, MONTELUKAST SODIUM, MONTELUKAST, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, ZOLMITRIPTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, EMPAGLIFLOZIN, LIRAGLUTIDE, LIRAGLUTIDE, DICLOFENAC SODIUM, COLCHICINE, PROPRANOLOL HYDROCHLORIDE, RIMEGEPANT SULFATE, UBROGEPANT, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, AZELAIC ACID, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, METHOTREXATE, TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION, |
||||
| 609 | 25060818 |
JP |
79 | 2 |
Malignant neoplasm progression, Immune-mediated enterocolitis, Drowning, Gingivitis, Motor dysfunction, Hypertension, Back pain, Malaise, Blood thyroid stimulating hormone increased, Arthralgia, Hypertension, Diarrhoea, Erythema, Hypoaesthesia, Off label use, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PACLITAXEL, |
||||
| 610 | 25060882 |
US |
56 | 2 |
Disorientation, Discomfort, Abdominal pain lower, Hot flush, Chills, Hypoaesthesia oral, Poisoning, Ocular hyperaemia, Eye irritation, Paraesthesia, Swelling, Burning sensation, Muscle spasms, Blister, Dizziness, Rash, Impaired healing, Limb injury, Headache, Pain in extremity, Feeling abnormal, Constipation, Gait disturbance, Blood pressure abnormal, Erythema, Nausea, Dry mouth, Chest pain, Tremor, Enuresis, Product dose omission issue, Joint swelling, Asthenia, Memory impairment, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE, GLATIRAMER ACETATE, |
||||
| 611 | 25060946 |
PT |
58 | 2 |
Skin exfoliation, Rash, Erythema, Pruritus, |
||||
IODIXANOL, CANDESARTAN CILEXETIL, LIRAGLUTIDE, EZETIMIBE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, FLURAZEPAM HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, GABAPENTIN, |
||||
| 612 | 25060997 |
US |
10 | 1 |
Erythema, Dyspnoea, |
||||
| 613 | 25062806 |
2 | ||
Skin fissures, Erythema, Skin irritation, Pain in extremity, Pain in extremity, Gait disturbance, |
||||
CAPECITABINE, CAPECITABINE, |
||||
| 614 | 25063356 |
|||
Sneezing, Pruritus, Flushing, Erythema, Throat irritation, Wheezing, Anaphylactic reaction, |
||||
EFGARTIGIMOD ALFA, |
||||
| 615 | 25064126 |
25 | 2 | |
Erythema, Flushing, Hyperhidrosis, Dyspnoea, Infusion related reaction, |
||||
MULTIPLE VITAMINS INJECTION, |
||||
| 616 | 25055742 |
US |
2 | |
Dry skin, Eyelid skin dryness, Eyelids pruritus, Erythema, Erythema of eyelid, Pruritus, Therapeutic product effect decreased, |
||||
DUPILUMAB, |
||||
| 617 | 25055799 |
US |
10 | 1 |
Skin mass, Skin swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 618 | 25055864 |
US |
2 | |
Eczema, Erythema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 619 | 25055931 |
US |
1 | 2 |
Cough, Rhinorrhoea, Restlessness, Teething, Eczema, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 620 | 25056218 |
US |
2 | |
Skin exfoliation, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 621 | 25054619 |
US |
2 | 2 |
Erythema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 622 | 25054649 |
US |
2 | |
Erythema, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 623 | 25055046 |
CA |
74 | 1 |
Bacterial infection, Blister, Blood pressure systolic increased, COVID-19, Cataract, Cellulitis, Cough, Depression, Dyspnoea, Erythema, Heart rate increased, Influenza like illness, Localised infection, Malaise, Nasopharyngitis, Oedema peripheral, Pruritus, Rhinorrhoea, Secretion discharge, Skin disorder, Type 2 diabetes mellitus, Vaccination site pain, Weight decreased, Product dose omission issue, Off label use, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, AMLODIPINE, ROFLUMILAST, GLYCOPYRROLATE, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, |
||||
| 624 | 25055094 |
US |
32 | 2 |
Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 625 | 25055281 |
CA |
||
Acne, Bone disorder, C-reactive protein increased, Eczema, Epistaxis, Joint swelling, Rash pustular, Road traffic accident, Weight increased, Wrist fracture, Arthralgia, Arthritis infective, Bronchitis, Chills, Cough, Drug hypersensitivity, Erythema, Headache, Nasopharyngitis, Pneumonia, Vision blurred, Visual impairment, Therapy partial responder, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, DESOXIMETASONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, PREDNISONE, RANITIDINE, SULFASALAZINE, LEVOTHYROXINE SODIUM, |
||||
| 626 | 25055403 |
CA |
64 | 1 |
Crohn^s disease, Diarrhoea, Erythema, Feeling hot, Hyperhidrosis, Hypersensitivity, Oedema peripheral, Off label use, Pain, Pain in extremity, Peripheral swelling, Pneumonia, Pruritus, Pyrexia, Skin infection, Skin ulcer, Soft tissue swelling, Solar lentigo, Swelling, Urticaria, Vomiting, Weight decreased, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, INFLIXIMAB, |
||||
| 627 | 25055478 |
IN |
||
Cerebral palsy, Seizure, Hypersensitivity, Peripheral swelling, Erythema, Erythema, |
||||
ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 628 | 25055597 |
US |
29 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Nasal dryness, Exfoliative rash, Erythema, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 629 | 25048329 |
US |
||
Exposure via skin contact, Accidental exposure to product by child, Erythema, |
||||
NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 630 | 25048815 |
CN |
64 | 2 |
Photosensitivity reaction, Erythema, Pruritus, |
||||
| 631 | 25049161 |
JP |
||
Peripheral arterial occlusive disease, Blister, Erythema, |
||||
| 632 | 25049263 |
CA |
68 | 2 |
Blister, Contusion, Erythema, Feeling hot, Haemorrhage, Pain, Pain of skin, Papule, Peripheral swelling, Product dose omission issue, Pustule, Skin burning sensation, Skin plaque, Sleep disorder, Swelling, Symptom recurrence, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DOXEPIN HYDROCHLORIDE, DOXEPN HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, RISEDRONATE SODIUM, BISOPROLOL FUMARATE, LEVOTHYROXINE SODIUM, |
||||
| 633 | 25049333 |
CA |
42 | 2 |
Abdominal distension, Anaphylactic reaction, Angioedema, Aphonia, Arthralgia, Aspartate aminotransferase decreased, Autoimmune disorder, Blood creatine phosphokinase decreased, Blood lactate dehydrogenase decreased, Blood pressure increased, C-reactive protein increased, Cervix carcinoma, Chest discomfort, Chronic spontaneous urticaria, Concomitant disease aggravated, Erythema, Eye swelling, Facial pain, Fatigue, Flushing, Gastrooesophageal reflux disease, Inappropriate schedule of product administration, Incorrect dose administered, Injection site pain, Injection site urticaria, Lip swelling, Lymphocyte count decreased, Malaise, Mobility decreased, Myasthenia gravis, Needle track marks, Neutrophil count increased, Peripheral swelling, Pharyngeal swelling, Product preparation error, Pruritus, Rash, Respiratory rate increased, Sensory loss, Somnolence, Stress, Swelling face, Therapeutic response decreased, Tongue disorder, Urticaria, Weight decreased, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, HYDROXYCHLOROQUINE SULFATE, LORATADINE, LORATADINE ORAL, PYRIDOSTIGMINE BROMIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MOMETASONE FUROATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PYRIDOSTIGMINE BROMIDE, |
||||
| 634 | 25049463 |
US |
47 | 2 |
Multiple sclerosis relapse, Abdominal pain upper, Rash, Erythema, Feeling hot, |
||||
DIMETHYL FUMARATE, |
||||
| 635 | 25049476 |
US |
46 | 2 |
Sunburn, Erythema, |
||||
GLATIRAMER ACETATE, TIZANIDINE, DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, EPINEPHRINE, OSELTAMIVIR PHOSPHATE, |
||||
| 636 | 25049691 |
GB |
||
Swelling face, Facial pain, Erythema, Rash, |
||||
DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, |
||||
| 637 | 25049862 |
CA |
47 | 2 |
Asthma, Contusion, Eczema, Eosinophil count increased, Erythema, Feeling abnormal, Food allergy, Dyspepsia, Haemoglobin decreased, Nasal congestion, Pain, Paraesthesia oral, Photosensitivity reaction, Pruritus, Psoriasis, Rash, Rash erythematous, Respiratory disorder, Respiratory tract congestion, Rhinitis, Rubber sensitivity, Scar, Skin hypopigmentation, Skin lesion, Swelling, Upper respiratory tract infection, Urticaria, Wheezing, Product dose omission issue, Drug ineffective, Temperature intolerance, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, EPINEPHRINE, |
||||
| 638 | 25049874 |
DE |
43 | 2 |
Anaphylactic shock, Paraesthesia oral, Oral discomfort, Swelling face, Swelling, Erythema, Burning sensation, Pruritus, Dyspnoea, |
||||
CEFUROXIME, |
||||
| 639 | 25049952 |
ES |
||
Face oedema, Erythema, Pruritus, Urticaria, Malaise, |
||||
ROSUVASTATIN, |
||||
| 640 | 25050084 |
IT |
65 | 2 |
Erythema, Dizziness, Hypotension, Oxygen saturation decreased, Abdominal pain, Retching, Defaecation urgency, |
||||
PACLITAXEL, |
||||
| 641 | 25050298 |
CA |
58 | 2 |
Bursitis, Asthma, Psoriasis, Food allergy, Retching, Fluid retention, Hepatic enzyme increased, Exposure during pregnancy, Pyrexia, Headache, Foetal death, Overdose, Cardiac failure, Infection, Temperature regulation disorder, Constipation, Drug ineffective, Joint swelling, Back pain, Prescribed overdose, Upper respiratory tract infection, Erythema, Hyponatraemia, Drug intolerance, Rash, Immunodeficiency, Hypertension, Pain, Decreased immune responsiveness, Drug hypersensitivity, Off label use, Product use issue, Hyperhidrosis, Infusion related reaction, Coeliac disease, Fatigue, Thrombocytopenia, Rheumatoid arthritis, Rash erythematous, Nausea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALBUTEROL SULFATE, ALBUTEROL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, TOCILIZUMAB, FLUTICASONE PROPIONATE, PROGESTERONE, BUPROPION HYDROCHLORIDE, CLONIDINE, |
||||
| 642 | 25050372 |
US |
2 | |
Back pain, Taste disorder, Cough, Erythema, Blood pressure increased, |
||||
FLUTEMETAMOL F-18, NASAL, SALINE, (SALINE), |
||||
| 643 | 25050493 |
ES |
58 | 1 |
Erythema, Face oedema, Pruritus, Urticaria, Malaise, |
||||
ROSUVASTATIN CALCIUM, |
||||
| 644 | 25050521 |
FR |
77 | 1 |
Pulmonary embolism, Diarrhoea, Erythema, Muscle spasms, Decreased appetite, Pruritus, Dysgeusia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, VALSARTAN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 645 | 25050979 |
CN |
24 | 2 |
Dyspnoea, Erythema, |
||||
MORPHINE SULFATE, |
||||
| 646 | 25051011 |
US |
2 | |
Neoplasm malignant, Erythema, Pruritus, Skin exfoliation, Rash, Vulvovaginal erythema, Vulvovaginal burning sensation, |
||||
INCLISIRAN, |
||||
| 647 | 25051013 |
SI |
1 | |
Skin reaction, Pruritus, Erythema, |
||||
INCLISIRAN, INCLISIRAN, INCLISIRAN, INCLISIRAN, INCLISIRAN, |
||||
| 648 | 25051098 |
56 | 1 | |
Pruritus, Swelling face, Erythema, |
||||
CEFAZOLIN SODIUM, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 649 | 25051127 |
DE |
51 | 2 |
Arrhythmia, Hypersensitivity, Dizziness, Tachycardia, Bradycardia, Erythema, Peripheral swelling, |
||||
FREMANEZUMAB-VFRM, |
||||
| 650 | 25051151 |
US |
84 | 2 |
Peripheral swelling, Erythema, Burning sensation, Pain in extremity, |
||||
ADALIMUMAB-BWWD, |
||||
| 651 | 25051433 |
PT |
71 | 2 |
Feeling hot, Erythema, |
||||
KETOROLAC TROMETHAMINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 652 | 25051468 |
SK |
||
Lupus-like syndrome, Non-Hodgkin^s lymphoma, Uveitis, Liver disorder, Body temperature, Skin reaction, Erythema, Oral candidiasis, Platelet count decreased, Drug ineffective, |
||||
GOLIMUMAB, USTEKINUMAB, INFLIXIMAB, ETANERCEPT, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 653 | 25051571 |
CH |
42 | 2 |
Neutropenia, Erythema, Maternal exposure before pregnancy, |
||||
OCRELIZUMAB, OCRELIZUMAB, |
||||
| 654 | 25051637 |
39 | 2 | |
Supraventricular tachycardia, Hypotension, Erythema, Nausea, Vomiting, Abdominal pain, Left ventricular dysfunction, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 655 | 25052075 |
US |
2 | |
Peripheral coldness, Erythema, Headache, |
||||
LECANEMAB, |
||||
| 656 | 25052430 |
US |
||
Dry skin, Skin burning sensation, Erythema, Skin exfoliation, Skin irritation, Rash papular, |
||||
ADAPALENE, |
||||
| 657 | 25052432 |
US |
||
Erythema, Skin burning sensation, Hypersensitivity, Skin fissures, |
||||
ADAPALENE, |
||||
| 658 | 25052440 |
US |
||
Skin burning sensation, Acne, Erythema, Skin irritation, Dry skin, Rash macular, |
||||
ADAPALENE, SALICYLIC ACID, SALICYLIC ACID, |
||||
| 659 | 25052459 |
US |
||
Skin burning sensation, Hypersensitivity, Eye swelling, Swelling face, Pain of skin, Erythema, Hand dermatitis, Acne, Urticaria, |
||||
ADAPALENE, ERGOCALCIFEROL, VITAMIN A, |
||||
| 660 | 25052462 |
US |
||
Skin burning sensation, Erythema, Pruritus, Rash, Dry skin, Skin irritation, |
||||
ADAPALENE, |
||||
| 661 | 25052464 |
US |
||
Dry skin, Erythema, |
||||
ADAPALENE, |
||||
| 662 | 25052465 |
US |
||
Erythema, Skin burning sensation, Skin irritation, Hypersensitivity, |
||||
ADAPALENE, |
||||
| 663 | 25052467 |
US |
||
Skin irritation, Skin burning sensation, Erythema, |
||||
ADAPALENE, SALICYLIC ACID, SALICYLIC ACID, |
||||
| 664 | 25052468 |
US |
||
Skin burning sensation, Erythema, |
||||
ADAPALENE, SALICYLIC ACID, SALICYLIC ACID, |
||||
| 665 | 25052469 |
US |
||
Skin burning sensation, Erythema, Dry skin, |
||||
ADAPALENE, |
||||
| 666 | 25052480 |
US |
||
Erythema, Rash, Pruritus, |
||||
ADAPALENE, |
||||
| 667 | 25052484 |
US |
||
Skin burning sensation, Dry skin, Erythema, Drug ineffective, |
||||
ADAPALENE, |
||||
| 668 | 25052489 |
US |
||
Dry skin, Skin burning sensation, Erythema, Skin irritation, |
||||
ADAPALENE, |
||||
| 669 | 25052605 |
US |
2 | |
Pharyngeal swelling, Erythema, Swelling face, |
||||
FLUOCINOLONE ACETONIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 670 | 25052770 |
US |
2 | |
Hypersensitivity, Erythema, |
||||
DUPILUMAB, |
||||
| 671 | 25052779 |
US |
2 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 672 | 25052792 |
US |
61 | 2 |
Asthma, Rash, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 673 | 25052793 |
US |
2 | |
Swelling, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 674 | 25052833 |
US |
2 | |
Lip blister, Erythema, Dry eye, |
||||
DUPILUMAB, |
||||
| 675 | 25052856 |
US |
50 | 1 |
Dermatitis atopic, Erythema, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 676 | 25052886 |
US |
65 | 2 |
Dermatitis atopic, Stress, Pruritus, Erythema, Rash macular, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 677 | 25052913 |
US |
15 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 678 | 25052927 |
US |
1 | |
Erythema, |
||||
DUPILUMAB, |
||||
| 679 | 25052959 |
US |
26 | 2 |
Eczema, Pruritus, Erythema, Dyshidrotic eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 680 | 25053038 |
US |
26 | 2 |
Eczema, Rash, Pruritus, Erythema, Nodule, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 681 | 25053082 |
US |
2 | |
Eye disorder, Flushing, Dizziness, Erythema, |
||||
DUPILUMAB, |
||||
| 682 | 25053150 |
US |
42 | 1 |
Rash, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 683 | 25053192 |
US |
17 | 1 |
Erythema, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 684 | 25053352 |
US |
65 | 1 |
Skin warm, Erythema, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 685 | 25053414 |
US |
13 | 1 |
Pruritus, Sleep disorder due to a general medical condition, Erythema, |
||||
DUPILUMAB, |
||||
| 686 | 25053420 |
US |
54 | 1 |
Dermatitis atopic, Eczema, Scab, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 687 | 25053481 |
US |
53 | 2 |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, |
||||
| 688 | 25053482 |
US |
17 | 1 |
Swelling, Erythema, Eye pruritus, Eye inflammation, |
||||
DUPILUMAB, |
||||
| 689 | 25053515 |
US |
55 | 2 |
Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 690 | 25053538 |
US |
3 | 1 |
Erythema, Pruritus, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 691 | 25053546 |
US |
35 | 2 |
Bone pain, Fatigue, Headache, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 692 | 25053614 |
US |
18 | 2 |
Condition aggravated, Pruritus, Erythema, Urticaria, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 693 | 25053623 |
US |
19 | 2 |
Dermatitis atopic, Erythema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 694 | 25053634 |
US |
15 | 2 |
Skin irritation, Erythema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 695 | 25053639 |
US |
18 | 1 |
Rash macular, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 696 | 25053673 |
US |
38 | 2 |
Skin ulcer, Scab, Skin burning sensation, Erythema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 697 | 25053683 |
US |
27 | 1 |
Skin fissures, Erythema, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 698 | 25053748 |
US |
39 | 2 |
Eczema, Erythema, Pruritus, Skin exfoliation, Palmar erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 699 | 25053825 |
US |
19 | 2 |
Malaise, Breast discomfort, Breast discharge, Pyrexia, Condition aggravated, Breast mass, Breast swelling, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 700 | 25053914 |
US |
46 | 2 |
Dermatitis atopic, Skin fissures, Pain of skin, Skin erosion, Hypoaesthesia, Skin exfoliation, Erythema, Dry skin, |
||||
DUPILUMAB, IRON, ERGOCALCIFEROL, VITAMIN C, LISDEXAMFETAMINE DIMESYLATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28